A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck

Silvia Vázquez, Juan J. Grau, José Á. García-Sáenz, Alicia Lozano, Carlos Garcı́a, Joan Carles, Antonio Irigoyen López, M. Mañós, Beatriz García-Paredes, E. del Barco,

International Journal of Radiation Oncology*Biology*Physics · 2015 · 29 citations · 19 references

Concepts

References

19